These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 16250657)
1. Structure-based virtual screening for low molecular weight chemical starting points for dipeptidyl peptidase IV inhibitors. Ward RA; Perkins TD; Stafford J J Med Chem; 2005 Nov; 48(22):6991-6. PubMed ID: 16250657 [TBL] [Abstract][Full Text] [Related]
2. In silico fragment-based discovery of DPP-IV S1 pocket binders. Rummey C; Nordhoff S; Thiemann M; Metz G Bioorg Med Chem Lett; 2006 Mar; 16(5):1405-9. PubMed ID: 16321524 [TBL] [Abstract][Full Text] [Related]
3. Discovery of DPP IV inhibitors by pharmacophore modeling and QSAR analysis followed by in silico screening. Al-Masri IM; Mohammad MK; Taha MO ChemMedChem; 2008 Nov; 3(11):1763-79. PubMed ID: 18989859 [TBL] [Abstract][Full Text] [Related]
4. A three-dimensional pharmacophore model for dipeptidyl peptidase IV inhibitors. Lu IL; Tsai KC; Chiang YK; Jiaang WT; Wu SH; Mahindroo N; Chien CH; Lee SJ; Chen X; Chao YS; Wu SY Eur J Med Chem; 2008 Aug; 43(8):1603-11. PubMed ID: 18207285 [TBL] [Abstract][Full Text] [Related]
5. Discovery, SAR, and X-ray structure of novel biaryl-based dipeptidyl peptidase IV inhibitors. Qiao L; Baumann CA; Crysler CS; Ninan NS; Abad MC; Spurlino JC; Desjarlais RL; Kervinen J; Neeper MP; Bayoumy SS; Williams R; Deckman IC; Dasgupta M; Reed RL; Huebert ND; Tomczuk BE; Moriarty KJ Bioorg Med Chem Lett; 2006 Jan; 16(1):123-8. PubMed ID: 16236500 [TBL] [Abstract][Full Text] [Related]
6. Crystal structures of DPP-IV (CD26) from rat kidney exhibit flexible accommodation of peptidase-selective inhibitors. Longenecker KL; Stewart KD; Madar DJ; Jakob CG; Fry EH; Wilk S; Lin CW; Ballaron SJ; Stashko MA; Lubben TH; Yong H; Pireh D; Pei Z; Basha F; Wiedeman PE; von Geldern TW; Trevillyan JM; Stoll VS Biochemistry; 2006 Jun; 45(24):7474-82. PubMed ID: 16768443 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of dipeptidyl peptidase IV (DPP IV) is one of the mechanisms explaining the hypoglycemic effect of berberine. Al-masri IM; Mohammad MK; Tahaa MO J Enzyme Inhib Med Chem; 2009 Oct; 24(5):1061-6. PubMed ID: 19640223 [TBL] [Abstract][Full Text] [Related]
8. Fluoro-olefins as peptidomimetic inhibitors of dipeptidyl peptidases. Van der Veken P; Senten K; Kertèsz I; De Meester I; Lambeir AM; Maes MB; Scharpé S; Haemers A; Augustyns K J Med Chem; 2005 Mar; 48(6):1768-80. PubMed ID: 15771423 [TBL] [Abstract][Full Text] [Related]
9. Diprolyl nitriles as potent dipeptidyl peptidase IV inhibitors. Zhao G; Taunk PC; Magnin DR; Simpkins LM; Robl JA; Wang A; Robertson JG; Marcinkeviciene J; Sitkoff DF; Parker RA; Kirby MS; Hamann LG Bioorg Med Chem Lett; 2005 Sep; 15(18):3992-5. PubMed ID: 16046120 [TBL] [Abstract][Full Text] [Related]
10. 1,3-disubstituted 4-aminopiperidines as useful tools in the optimization of the 2-aminobenzo[a]quinolizine dipeptidyl peptidase IV inhibitors. Lübbers T; Böhringer M; Gobbi L; Hennig M; Hunziker D; Kuhn B; Löffler B; Mattei P; Narquizian R; Peters JU; Ruff Y; Wessel HP; Wyss P Bioorg Med Chem Lett; 2007 Jun; 17(11):2966-70. PubMed ID: 17418568 [TBL] [Abstract][Full Text] [Related]
11. 4-aminophenylalanine and 4-aminocyclohexylalanine derivatives as potent, selective, and orally bioavailable inhibitors of dipeptidyl peptidase IV. Duffy JL; Kirk BA; Wang L; Eiermann GJ; He H; Leiting B; Lyons KA; Patel RA; Patel SB; Petrov A; Scapin G; Wu JK; Thornberry NA; Weber AE Bioorg Med Chem Lett; 2007 May; 17(10):2879-85. PubMed ID: 17350841 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of dipeptidyl peptidase-IV (DPP-IV) by atorvastatin. Taldone T; Zito SW; Talele TT Bioorg Med Chem Lett; 2008 Jan; 18(2):479-84. PubMed ID: 18068977 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationships of potent 4-fluoro-2-cyanopyrrolidine dipeptidyl peptidase IV inhibitors. Fukushima H; Hiratate A; Takahashi M; Mikami A; Saito-Hori M; Munetomo E; Kitano K; Chonan S; Saito H; Suzuki A; Takaoka Y; Yamamoto K Bioorg Med Chem; 2008 Apr; 16(7):4093-106. PubMed ID: 18243000 [TBL] [Abstract][Full Text] [Related]
14. Selectivity among dipeptidyl peptidases of the S9b family. Bjelke JR; Kanstrup AB; Rasmussen HB Cell Mol Biol (Noisy-le-grand); 2006 Dec; 52(4):3-7. PubMed ID: 17543192 [TBL] [Abstract][Full Text] [Related]
15. The structural comparison of the bacterial PepX and human DPP-IV reveals sites for the design of inhibitors of PepX activity. Rigolet P; Xi XG; Rety S; Chich JF FEBS J; 2005 Apr; 272(8):2050-9. PubMed ID: 15819895 [TBL] [Abstract][Full Text] [Related]
16. Crystal structure of human dipeptidyl peptidase IV/CD26 in complex with a substrate analog. Rasmussen HB; Branner S; Wiberg FC; Wagtmann N Nat Struct Biol; 2003 Jan; 10(1):19-25. PubMed ID: 12483204 [TBL] [Abstract][Full Text] [Related]
18. Potent and selective proline derived dipeptidyl peptidase IV inhibitors. Edmondson SD; Mastracchio A; Beconi M; Colwell LF; Habulihaz B; He H; Kumar S; Leiting B; Lyons KA; Mao A; Marsilio F; Patel RA; Wu JK; Zhu L; Thornberry NA; Weber AE; Parmee ER Bioorg Med Chem Lett; 2004 Oct; 14(20):5151-5. PubMed ID: 15380217 [TBL] [Abstract][Full Text] [Related]
19. Synthesis, structure-activity relationship, and pharmacophore modeling studies of pyrazole-3-carbohydrazone derivatives as dipeptidyl peptidase IV inhibitors. Wu D; Jin F; Lu W; Zhu J; Li C; Wang W; Tang Y; Jiang H; Huang J; Liu G; Li J Chem Biol Drug Des; 2012 Jun; 79(6):897-906. PubMed ID: 22381062 [TBL] [Abstract][Full Text] [Related]